GlassScriptPhysician profile
Josef Koberlein
NPI 1396483020
$2,963.76
in general payments reported to CMS, 2019-2025
20 companies · $1,000 in 2025
The $1,000 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $182 · 2023: $938 · 2024: $843 · 2025: $1,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,781.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $359.17 | 2022-2025 | |
| Dompe US, INC. | $315.13 | 2024-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $314.33 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $274.33 | 2024-2025 | Vevye |
| Alcon Vision LLC | $220.72 | 2022-2025 | Tryptyr, Clareon, Simbrinza |
| Bausch & Lomb Americas INC. | $198.44 | 2023-2025 | Infuse, Xiidra, Miebo |
| Apellis Pharmaceuticals, INC. | $187.26 | 2023-2024 | Syfovre |
| Sun Pharmaceutical Industries INC. | $165.27 | 2023-2025 | Cequa |
| Oyster Point Pharma, INC. | $164.33 | 2022-2023 | Tyrvaya |
| Glaukos Corporation | $158.88 | 2024 | |
| Biotissue Holdings INC. | $140.56 | 2023-2025 | |
| Coopervision INC. | $109.12 | 2024 | Misight Contact Lens |
| Horizon Therapeutics Plc | $105.36 | 2023 | Tepezza |
| Mallinckrodt Hospital Products INC. | $43.26 | 2022-2024 | Acthar |
| Genentech USA, INC. | $42.42 | 2024 | Vabysmo, Susvimo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coherus Oncology, INC. | $37.77 | 2023 | |
| Alimera Sciences, INC. | $36.18 | 2022 | |
| Astellas Pharma US INC | $33.49 | 2023 | |
| Carl Zeiss Meditec, INC. | $33.00 | 2022 | |
| Thea Pharma INC. | $24.74 | 2023 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Josef Koberlein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.